Laszlo Boros, MD

Chief Scientific Advisor

Dr. Boros is currently an Associate Professor of Pediatrics at UCLA and the Co-Director of the Stable Isotope Research Laboratory at Harbor-UCLA Medical Center with a primary focus on studying cancer cell metabolism with the use of a specifically designed glucose tracer and mass spectroscopy. Born and educated in Hungary, Dr. Boros medical background includes three years of gastroenterology and pancreatology, focusing on chronic pancreatitis and pancreatic cancer. He spent two years as a visiting scholar in Essen, Germany, studying various animal models of chronic pancreatitis. In 1990, he moved to Columbus, Ohio, where he joined the history-making laboratory of Drs. Zollinger and Ellison, who described hormonal regulatory mechanisms involved in pancreatic cancer growth with a primary emphasis on diagnostics and treatment. In 1995 he became the lead investigator to apply stable isotope technologies to study cancer growth in vitro and in animal models at UCLA. He is an expert in using metabolic profiling and nanotechnology to further understanding of aggressive growth in inflammatory breast cancer and other particularly aggressive cancers. Dr. Boros also participates in research projects targeting population metabolic disorders, such as diabetes and obesity, and is  involved in discovering the underlying mechanisms of rare metabolic disorders arising from genetic mutations affecting vitamin transport.

Dr. Boros currently collaborates with the Harvard School of Medicine, Cedar Sinai Medical Center, Oklahoma University and the University of Colorado Health Science Center. He also serves as an advisor and consultant to two major pharmaceutical companies, focused on time-efficient and cost-effective development of therapeutic drugs.

Contact Dr. Boros